LH
39
-3
GWW
62
-2
DNB
50
-4
FCX
62
-3
IR
60
-3
ABT
62
2
PDCO
47
-2
CMS
60
2
RIG
32
-3
VRSN
54
-2
XRAY
25
-3
ICE
52
-3
AEP
51
4
TEL
61
-2
GPC
22
3
NEE
49
3
SPG
58
-5
PSX
32
-2
RRC
50
7
PNR
63
-2
LH
39
-3
GWW
62
-2
DNB
50
-4
FCX
62
-3
IR
60
-3
ABT
62
2
PDCO
47
-2
CMS
60
2
RIG
32
-3
VRSN
54
-2
XRAY
25
-3
ICE
52
-3
AEP
51
4
TEL
61
-2
GPC
22
3
NEE
49
3
SPG
58
-5
PSX
32
-2
RRC
50
7
PNR
63
-2
Financhill
Back

Ultragenyx Pharmaceutical Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
54.80
Seasonality Move:
12.42%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.56
Seasonality Move:
-16.74%
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.69. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.69
    The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: -417236 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.89 - 57.39) Sell
Bollinger Bands (100): (42.72 - 56.34) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 43.34 Sell
Chaikin Money Flow: -28590 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 2.17) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.79 Sell
20-day SMA: 55.04 Sell
50-day SMA: 55.76 Sell
200-day SMA: 47.58 Buy
8-day EMA: 55.24 Sell
20-day EMA: 55.36 Sell
50-day EMA: 54.2 Buy
200-day EMA: 48.52 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.58 Buy
200-day SMA: 2.87 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.63 Sell
50-day EMA: 0.77 Sell
200-day EMA: 6.77 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):